SNP in the genome-wide association study hotspot on chromosome 9p21 confers susceptibility to diabetic nephropathy in type 1 diabetes

Diabetologia

Volumn 55, Issue 9, 2012, Pages 2386-2393

  Fagerholm, E ^a,b   Ahlqvist, E ^c   Forsblom, C ^a,b   Sandholm, N ^a,b   Syreeni, A ^a,b   Parkkonen, M ^a,b   McKnight, A J ^d   Tarnow, L ^e   Maxwell, A P ^d   Parving, H H ^f   Groop, L ^c   Groop, P H ^a,b,g  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c LUND UNIVERSITY   (Sweden)

^d QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^e STENO DIABETES CENTER   (Denmark)

^f Rigshospitalet   (Denmark)

^g BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

CDKN2A; Diabetic nephropathy; Genetics; rs10811661; Type 1 diabetes mellitus; Type 2 diabetes mellitus

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 2B;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; CDKN2A GENE; CDKN2B GENE; CHROMOSOME 9P; COHORT ANALYSIS; CONTROLLED STUDY; DIABETIC ANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE SEVERITY; FINLAND; GENE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MOLECULAR PATHOLOGY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALBUMINURIA; CHROMOSOMES, HUMAN, PAIR 9; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FINLAND; GENES, P16; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; PARENTS; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 84866130556     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-012-2587-0     Document Type: Article

References (37)

1. Harjutsalo V, Katoh S, Sarti C, Tajima N, Tuomilehto J (2004) Population-based assessment of familial clustering of diabetic nephropathy in type 1 diabetes. Diabetes 53:2449-2454
2. Seaquist ER, Goetz FC, Rich S, Barbosa J (1989) Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 320:1161-1165
3. Fagerudd JA, Pettersson-Fernholm KJ, Gronhagen-Riska C, Groop PH (1999) The impact of a family history of type II (non-insulin-dependent) diabetes mellitus on the risk of diabetic nephropathy in patients with type I (insulin-dependent) diabetes mellitus. Diabetologia 42:519-526
4. Hadjadj S, Duengler F, Torremocha F et al (2007) Maternal history of type 2 diabetes is associated with diabetic nephropathy in type 1 diabetic patients. Diabetes Metab 33:37-43
5. Erbey JR, Kuller LH, Becker DJ, Orchard TJ (1998) The association between a family history of type 2 diabetes and coronary artery disease in a type 1 diabetes population. Diabetes Care 21:610-614
6. Mäkimattila S, Ylitalo K, Schlenzka A et al (2002) Family histories of type II diabetes and hypertension predict intima-media thickness in patients with type I diabetes. Diabetologia 45:711-718
7. Scott LJ, Mohlke KL, Bonnycastle LL et al (2007) A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316:1341-1345
8. Diabetes Genetics Initiative of Broad Institute of Harvard and MIT, Lund University, and Novartis Institutes of BioMedical Research, Saxena R, Voight BF et al (2007) Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316:1331-1336
9. Thorn LM, Forsblom C, Waden J et al (2009) Effect of parental type 2 diabetes on offspring with type 1 diabetes. Diabetes Care 32:63-68
10. Levey AS, Coresh J, Greene T et al (2006) Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 145:247-254
11. McKnight AJ, Patterson CC, Pettigrew KA et al (2010) A GREM1 gene variant associates with diabetic nephropathy. J Am Soc Nephrol 21:773-781
12. Lindholm E, Agardh E, Tuomi T, Groop L, Agardh CD (2001) Classifying diabetes according to the new WHO clinical stages. Eur J Epidemiol 17:983-989
13. Purcell S, Neale B, Todd-Brown K et al (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559-575
14. Purcell S, Cherny SS, Sham PC (2003) Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19:149-150
15. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557-560
16. Newton-Cheh C, Hirschhorn JN (2005) Genetic association studies of complex traits: design and analysis issues. Mutat Res 573:54-69
17. McPherson R, Pertsemlidis A, Kavaslar N et al (2007) A common allele on chromosome 9 associated with coronary heart disease. Science 316:1488-1491
18. Helgadottir A, Thorleifsson G, Manolescu A et al (2007) A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 316:1491-1493
19. Gretarsdottir S, Baas AF, Thorleifsson G et al (2010) Genome-wide association study identifies a sequence variant within the DAB2IP gene conferring susceptibility to abdominal aortic aneurysm. Nat Genet 42:692-697
20. Bishop DT, Demenais F, Iles MM et al (2009) Genome-wide association study identifies three loci associated with melanoma risk. Nat Genet 41:920-925
21. Wrensch M, Jenkins RB, Chang JS et al (2009) Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet 41:905-908
22. Shete S, Hosking FJ, Robertson LB et al (2009) Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet 41:899-904
23. Turnbull C, Ahmed S, Morrison J et al (2010) Genome-wide association study identifies five new breast cancer susceptibility loci. Nat Genet 42:504-507
24. Helgadottir A, Thorleifsson G, Magnusson KP et al (2008) The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nat Genet 40:217-224
25. Broadbent HM, Peden JF, Lorkowski S et al (2008) Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p. Hum Mol Genet 17:806-814
26. McKnight AJ, Maxwell AP, Fogarty DG, Sadlier D, Savage DA, Warren 3/UK GoKinD Study Group (2009) Genetic analysis of coronary artery disease single-nucleotide polymorphisms in diabetic nephropathy. Nephrol Dial Transplant 24:2473-2476
27. Freedman BI, Langefeld CD, Rich SS et al (2004) A genome scan for ESRD in black families enriched for nondiabetic nephropathy. J Am Soc Nephrol 15:2719-2727
28. Yap KL, Li S, Munoz-Cabello AM et al (2010) Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell 38:662-674
29. Krishnamurthy J, Torrice C, Ramsey MR et al (2004) Ink4a/Arf expression is a biomarker of aging. J Clin Invest 114:1299-1307
30. Melk A, Schmidt BM, Takeuchi O, Sawitzki B, Rayner DC, Halloran PF (2004) Expression of p16INK4a and other cell cycle regulator and senescence associated genes in aging human kidney. Kidney Int 65:510-520
31. Sis B, Tasanarong A, Khoshjou F, Dadras F, Solez K, Halloran PF (2007) Accelerated expression of senescence associated cell cycle inhibitor p16INK4A in kidneys with glomerular disease. Kidney Int 71:218-226
32. Wolf G, Wenzel U, Ziyadeh FN, Stahl RA (1999) Angiotensin converting-enzyme inhibitor treatment reduces glomerular p16INK4 and p27Kip1 expression in diabetic BBdp rats. Diabetologia 42:1425-1432
33. Verzola D, Gandolfo MT, Gaetani G et al (2008) Accelerated senescence in the kidneys of patients with type 2 diabetic nephropathy. Am J Physiol Renal Physiol 295:F1563-F1573
34. Jorsal A, Tarnow L, Lajer M et al (2008) The PPAR gamma 2 Pro12Ala variant predicts ESRD and mortality in patients with type 1 diabetes and diabetic nephropathy. Mol Genet Metab 94:347-351
35. Forsblom CM, Groop PH, Ekstrand A, Groop LC (1992) Predictive value of microalbuminuria in patients with insulin-dependent diabetes of long duration. BMJ 305:1051-1053
36. Caramori M, Fioretto P, Mauer M (2000) The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient? Diabetes 49:1399-1408
37. Bangstad HJ, Osterby R, Dahl-Jorgensen K et al (1993) Early glomerulopathy is present in young, type 1 (insulin-dependent) diabetic patients with microalbuminuria. Diabetologia 36:523-529